[go: up one dir, main page]

HK1171686A - Methods and compositions for treatment of pulmonary fibrotic disorders - Google Patents

Methods and compositions for treatment of pulmonary fibrotic disorders Download PDF

Info

Publication number
HK1171686A
HK1171686A HK12112587.0A HK12112587A HK1171686A HK 1171686 A HK1171686 A HK 1171686A HK 12112587 A HK12112587 A HK 12112587A HK 1171686 A HK1171686 A HK 1171686A
Authority
HK
Hong Kong
Prior art keywords
compositions
treatment
methods
fibrotic disorders
pulmonary fibrotic
Prior art date
Application number
HK12112587.0A
Other languages
Chinese (zh)
Inventor
Rhyannon Spangler
Victoria Smith
Original Assignee
Gilead Biologics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gilead Biologics, Inc. filed Critical Gilead Biologics, Inc.
Publication of HK1171686A publication Critical patent/HK1171686A/en

Links

HK12112587.0A 2009-08-21 2010-08-20 Methods and compositions for treatment of pulmonary fibrotic disorders HK1171686A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US61/235,846 2009-08-21

Publications (1)

Publication Number Publication Date
HK1171686A true HK1171686A (en) 2013-04-05

Family

ID=

Similar Documents

Publication Publication Date Title
ZA201201290B (en) Methods and compositions for treatment of pulmonary fibrotic disorders
WO2011049960A9 (en) Compositions and methods for the treatment of sinonasal disorders
PL2467372T3 (en) Treatment of bdnf-related disorders using laquinimod
EP2293800A4 (en) Compositions and methods for treatment of ear disorders
EP2405755A4 (en) Methods and compositions for the treatment of metabolic and cardiovascular disorders
WO2011071995A9 (en) Compounds and methods of treating ocular disorders
EP2482814A4 (en) Methods and compositions for treatment of ocular fibrosis
ZA201102745B (en) Methods of treating pulmonary disorders with liposmal amikacin formulations
IL215856A0 (en) Compositions and methods for treatment of cardiovascular disease
AU2010260585A8 (en) Compositions and methods for treatment of Multiple Sclerosis
WO2011085351A9 (en) Method of treating kcnq related disorders
WO2011112588A9 (en) Compositions and methods for treating inflammatory disorders
ZA201106076B (en) Treatment of insulin-resistant disorders
WO2011137427A9 (en) Compositions and methods for treating pulmonary conditions
EP2490721A4 (en) Compositions, methods for treatment, and diagnoses of autoimmunity-related disorders and methods for making such compositions
WO2011062906A9 (en) Treatment of atrial fibriallation
WO2009120799A9 (en) Methods of treating fibrotic disorders
WO2011153525A9 (en) Methods for treatment of nephrotic syndrome and related conditions
HU0900231D0 (en) Compositions for the treatment of allergic disorders
WO2011009119A9 (en) Compositions and methods for diagnosing and treating fibrotic disorders
EP2563923A4 (en) Compositions and methods for reduced scarring and for treatment of fibrosis
HK1171686A (en) Methods and compositions for treatment of pulmonary fibrotic disorders
WO2010111374A9 (en) Compositions and methods for alleviating skin disorders
AU2009904062A0 (en) Compositions and method of treatment of spinal disorders III
AU2011904449A0 (en) Compositions and methods for the treatment of fibrosis and fibrotic diseases